British PM Johnson says AstraZeneca's India COVID shot should be accepted in travel schemes

About 5 million people in Britain are thought to have had the vaccine made by Serum Institute in India, known as Covishield.

Agencies
"I see no reason at all why the MHRA-approved vaccines should not be recognised as part of the vaccine passports and I'm very confident that that will not prove to be a problem," Johnson said
British Prime Minister Boris Johnson on Friday said he saw no reason why people who received Indian-made AstraZeneca COVID-19 vaccines should be left out of vaccine passport schemes after the European Union did not initially recognise it.

About 5 million people in Britain are thought to have had the vaccine made by Serum Institute in India, known as Covishield.

"I see no reason at all why the MHRA-approved vaccines should not be recognised as part of the vaccine passports and I'm very confident that that will not prove to be a problem," Johnson said at a joint news conference with Angela Merkel, referring to Britain's medicines regulator.

Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › News › International › World News › British PM Johnson says AstraZeneca's India COVID shot should be accepted in travel schemes
Text Size:AAA
Success
This article has been saved

*

+